Dashboard
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 0.15% and Operating profit at -4.84% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Capital Employed (avg) of 6.55% signifying low profitability per unit of total capital (equity and debt)
The company has declared Negative results for the last 14 consecutive quarters
Risky - Negative Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
USD 110 Million (Micro Cap)
NA (Loss Making)
NA
64.46%
-3.15
43.14%
-0.15
Total Returns (Price + Dividend) 
Trinseo Plc for the last several years.
Risk Adjusted Returns v/s 
News
Is Trinseo Plc technically bullish or bearish?
As of 10 September 2025, the technical trend for Trinseo Plc has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the daily moving averages and the KST on a weekly basis. The MACD shows mildly bullish signals on both weekly and monthly time frames, but this is countered by the overall bearish signals from Bollinger Bands and OBV. The stock has underperformed significantly against the S&P 500 over the longer term, with a year-to-date return of -48.63% compared to the S&P 500's 12.22%, and a 3-year return of -89.15% versus 70.41% for the index....
Read MoreIs Trinseo Plc overvalued or undervalued?
As of 2 November 2022, Trinseo Plc's valuation grade changed from expensive to risky, indicating a deterioration in its financial standing. The company appears to be overvalued, particularly given its negative price-to-book value of -0.21 and an EV to EBITDA ratio of 14.30, which suggests that it is trading at a premium relative to its earnings potential. Additionally, the EV to Sales ratio of 0.73 further reinforces concerns about its valuation compared to its revenue generation capabilities. In comparison to its peers, Trinseo's valuation metrics are concerning; for instance, Westlake Chemical Partners LP, which is rated very attractive, has a P/E ratio of 2.42, while Mativ Holdings, Inc. is also rated risky with a significantly higher EV to EBITDA of 9.54. Trinseo's recent stock performance has been notably poor, with a year-to-date return of -48.63%, starkly underperforming the S&P 500's gain of 12.22%...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 46 Schemes (37.95%)
Held by 77 Foreign Institutions (29.1%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is -0.06% vs -4.47% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is -33.54% vs 32.99% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -4.41% vs -25.98% in Dec 2023
YoY Growth in year ended Dec 2024 is 50.31% vs -63.86% in Dec 2023






